Long HCC pipeline marks change for previously stagnant market
Many new therapies entering the market have different mechanisms of action (MOA) and are aiming to meet needs in different…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Lenvima
US FDA declines to approve Merck and Eisai’s liver cancer combo therapy
The FDA's complete response letter cited lack of sufficient evidence that the Keytruda-Lenvima combination therapy had a…